Chainlink's price has dropped 8.53% in the last 24 hours, continuing a weekly decline of 13.0%, now sitting at $28.4. Trading volume has decreased by 34.0% over the week, while circulating supply has slightly increased to 626.85 million, representing 62.68% of its max supply. Currently, LINK ranks #13 in market cap at $15.42 billion.
Sonic and Injective are collaborating to create the first cross-chain Smart Agent Hub, integrating the Solana and Injective ecosystems. This innovative platform will utilize Sonic’s HyperGrid technology to enable seamless asset transfer and a unified developer experience, fostering new economic opportunities in AI agents across various sectors. Initial testnet deployment is expected in Q1 2025, aiming to revolutionize cross-chain applications in gaming, DeFi, and social platforms.
A prominent crypto advocacy group is urging the SEC to reassess all crypto-related cases under the incoming Trump administration, anticipating a more cooperative regulatory environment. The proposal emphasizes the need for clear regulations and a shift away from "regulation by enforcement" to foster trust within the digital asset community. Additionally, new FASB guidance mandates that companies report digital assets at fair market value starting in 2025, enhancing transparency for investors.
Solana's developer Anza has proposed implementing slashing to enhance validator accountability, a feature absent in the network's history. This would allow penalties for validators who create duplicate blocks, introducing new risks for SOL stakers, particularly if their chosen validators face slashing. While the proposal has garnered early support, it remains in the early stages, with potential rollout not expected until late summer 2025.
Roche's Parkinson's drug, prasinezumab, has failed a Phase IIb trial, despite showing potential clinical efficacy in delaying motor progression. While the results indicated positive trends in secondary endpoints, they lacked statistical significance, prompting analysts to call the data "promising but leaves uncertainty." Roche plans to continue related studies and may consider a new trial to further explore the findings.
Sui (SUI) has surged over 813% in 2024, recently hitting a yearly high of $4.9, driven by increased user activity and the integration of Backpack with its blockchain. Analysts predict potential resistance levels at $5.71 and $6.80, with a long-term target of $20, contingent on breaking key resistance levels. Despite market fluctuations, Sui is gaining traction, outperforming major cryptocurrencies like Solana and Ethereum, with significant net inflows.
UBS has raised its price target for Netflix from $825 to $1,040, citing strong operational momentum and a robust content slate that will drive subscriber growth. The firm anticipates Netflix will add 32 million subscribers in 2024 and 22 million in 2025, benefiting from industry shifts and increased ad revenue. With ongoing investments in original content, Netflix is positioned to outperform competitors amid a consolidating media landscape.
UBS has raised its price target for Netflix from $825 to $1,040, citing strong operational momentum and a robust content slate that will drive subscriber growth. The firm anticipates Netflix will add 32 million subscribers in 2024 and 22 million in 2025, benefiting from industry shifts and increased ad revenue. The company's ability to grow revenue faster than content spending is expected to enhance free cash flow and operating leverage.
Novartis is closing MorphoSys sites in Munich and Boston, resulting in approximately 330 layoffs, as part of its integration strategy following the €2.7 billion acquisition earlier this year. The decision aligns with a focus on prioritizing R&D programs, particularly the delayed approval pathway for the oncology candidate pelabresib. This trend of post-acquisition job cuts has been observed across several major pharma companies in recent years.
The Dow Jones Industrial Average rebounded by 1.1% following stronger-than-expected GDP growth of 3.1% and a drop in jobless claims to 220,000. However, Micron Technology's stock plummeted over 16% due to a disappointing outlook, while Nvidia attempted a recovery after a five-session decline. Other notable market movements included Darden Restaurants surging 14% and Lennar falling 4%.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings